ipsoprubart

News

Electra Therapeutics has moved ahead with plans for an IPO, seeking to raise funds for its drug for the rare and life-threatening disease sHLH.

News

Egetis has launched the first-ever therapy for the ultra-rare disease MCT8 deficiency in the US, with a list price of $950,000 per year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.